Antiarrhythmic therapy for narrow QRS supraventricular tachyarrhythmias in newborns and infants in the first year of life: Potent tools to be handled with care [PDF]
Indian Pacing and Electrophysiology JournalSupraventricular tachyarrhythmias pose a significant challenge in neonates and infants, particularly within the first year of life, where prompt and effective management is crucial.
Giovanni Domenico Ciriello +13 more
doaj +3 more sources
Revisiting Antiarrhythmic Drug Therapy for Atrial Fibrillation: Reviewing Lessons Learned and Redefining Therapeutic Paradigms [PDF]
Frontiers in Pharmacology, 2020 Since the clinical use of digitalis as the first pharmacological therapy for atrial fibrillation (AF) 235 years ago in 1785, antiarrhythmic drug therapy has advanced considerably and become a cornerstone of AF clinical management.
Meng Geng, Andrew Lin, Thao P. Nguyen
doaj +4 more sources
Current strategies of antiarrhythmic drug therapy for paroxysmal atrial fibrillation [PDF]
Journal of Arrhythmia, 2012 Atrial fibrillation is now recognized as a significant medical and social problem. Atrial fibrillation not only causes cardiovascular complications, including thromboembolism and heart failure, but also decreases the survival of patients with impaired ...
Takashi Komatsu
doaj +2 more sources
Safety and interaction of direct oral anticoagulants with antiarrhythmic drugs
Российский кардиологический журнал, 2021 The use of direct oral anticoagulants minimized the risks associated with vitamin K antagonist (warfarin) therapy. Currently, direct oral anticoagulants have priority over warfarin for the prevention of thromboembolic events in patients with atrial ...
B. A. Tatarsky, N. V. Kazyonnova
doaj +3 more sources
Prediction of antiarrhythmic therapy effectiveness in children
Российский кардиологический журнал, 2019 Aim. To optimize treatment tactics in children with arrhythmias based on the evaluation and prediction of the therapy efficacy.Material and methods. Prospective cohort study was performed from 2007 to 2017 A total of 100 patients aged 0 to 7 years with ...
L. I. Svintsova +2 more
doaj +3 more sources
Arrhythmogenic Right Ventricular Cardiomyopathy - Antiarrhythmic Therapy. [PDF]
Arrhythm Electrophysiol Rev, 2015 Arrhythmogenic right ventricular cardiomyopathy is an inherited disorder characterised by progressive replacement of ventricular myocardium by fibrofatty tissue that predisposes patients to ventricular arrhythmias, heart failure and sudden death ...
Ermakov S, Scheinman M.
europepmc +2 more sources
Safety issues of antiarrhythmic therapy for atrial fibrillation
Клинический разбор в общей медицинеThe article discusses the safety of antiarrhythmic therapy for atrial fibrillation in the light of the development of cardiac and non-cardiac side effects, the presence of drug-drug interactions of antiarrhythmic drugs in the near (with anticoagulants ...
I.I. Reznik , Ya.G. Bozhko
doaj +2 more sources
Российский кардиологический журнал, 2020 Aim. To individualize premature ventricular contraction (PVC) therapy in patients without structural cardiac changes by identifying potentially effective antiarrhythmic agents.Material and methods.
A. I. Olesin +3 more
doaj +3 more sources
Российский кардиологический журнал, 2003 The work has studied opportunities for ТЕ EPS in serial testing of antiarrhythmic drugs testing to prevent recurrent arrhythmia in patients with atrial fibrillation.
K. A. Skiba, V. V. Petry, V. A. Sulimov
doaj +1 more source
Ventricular tachycardia characteristics and outcomes with catheter ablation vs. antiarrhythmic therapy: insights from the VANISH trial [PDF]
Europace, 2022 Marc W Deyell +2 more
exaly +2 more sources